Effect of goniothalamin on the development of Ehrlich solid tumor in mice

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 18, 2010, Pages 6742-6747

  Vendramini Costa, Débora Barbosa ^a   Castro, Ilton Barros Daltro De ^a   Ruiz, Ana Lúcia Tasca Góis ^a   Marquissolo, Cilene ^a   Pilli, Ronaldo Aloise ^a   Carvalho, João Ernesto De ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cancer; Ehrlich solid tumor; Goniothalamin; Mice

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CARRAGEENAN; DOXORUBICIN; FLUOROURACIL; GONIOTHALAMIN; PIROXICAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SIZE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; EHRLICH ASCITES TUMOR; ENANTIOMER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PAW EDEMA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CARRAGEENAN; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EDEMA; HUMANS; MICE; PYRONES; STEREOISOMERISM;

ANIMALIA; MUS;

EID: 77956345329     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.07.053     Document Type: Article

References (35)

1. Â. de Fátima, W.F. Zambuzzi, L.V. Modolo, C.A.B. Tarsitano, F.R. Gadelha, S. Hyslop, J.E. de Carvalho, I. Salgado, C.V. Ferreira, and R.A. Pilli Chem. Biol. Interact. 176 2008 143
2. S. Inayat-Hussain, K. Chan, N. Rajab, L. Din, S. Chow, A. Kizilors, F. Farzaneh, and G. Williams Toxicol. Lett. 193 2010 108
3. P. Kasaplar, O. Yilmazer, and A. Cair Bioorg. Med. Chem. 17 2009 311
4. S.H. Inayat-Hussain, A.B. Osman, L.B. Din, A.M. Ali, R.T. Snowden, M. MacFarlane, and K. Cain FEBS Lett. 456 1999 379
5. S.H. Inayat-Hussain, B.O. Annuar, L.B. Din, A.M. Ali, and D. Ross Toxicol. In Vitro 17 2003 433
6. A.H.L. Pihie, J. Stanslas, and L. Bin Din Anticancer Res. 18 1998 1739
7. N.F. Rajab, Z.A. Hamid, H. Hassan, M.A. Ali, L.B. Din, and S.H. Inayat-Hussain Environ. Mutagen Res. 27 2005 161
8. W.Y. Chen, C.C. Wu, Y.H. Lan, F.R. Chang, C.M. Teng, and Y.C. Wu Eur. J. Pharmacol. 522 2005 20
9. Â. de Fátima, L.K. Kohn, M.A. Antônio, J.E. de Carvalho, and R.A. Pilli Bioorg. Med. Chem. 13 2005 2927
10. Â. de Fátima, L.K. Kohn, J.E. Carvalho, and R.A. Pilli Bioorg. Med. Chem. 14 2006 622
11. Wach, J.-Y.; et al. Bioorg. Med. Chem. Lett. in press. doi:10.1016/j.bmcl.2010.03.049.
12. O. Tredan, C.M. Galmarini, K. Patel, and I.F. Tannock J. Natl. Cancer Inst. 99 2007 1441
13. J.A. Smith, H. Ngo, M.C. Martin, and J.K. Wolf Gynecol. Oncol. 98 2005 141
14. F.R. Nascimento, G.V. Cruz, P.V. Pereira, M.C. Maciel, L.A. Silva, A.P.S. Azevedo, E.S.B. Barroqueiro, and R.N.M. Guerra Life Sci. 78 2006 2650
15. S.C.S. Oloris, M.L.Z. Dagli, and J.L. Guerra Life Sci. 71 2002 717
16. J.A. Segura, L.G. Barbero, and J. Márquez Immunol. Lett. 74 2000 111
17. N.M. Gomes, C.M. Rezende, S.P. Fontes, A.M.C. Hovell, R.G. Landgraf, M.E. Matheus, A.C. Pinto, and P.D. Fernandes J. Ethnopharmacol. 119 2008 179
18. H.L. Stewart Cancer Res. 19 1959 804
19. A.J. Schetter, N.H.H. Heegaard, and C.C. Harris Carcinogenesis 31 2010 37
20. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paull, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo, and M. Boyd J. Nat. Cancer Inst. 83 1991 757
21. R. Shoemaker Nat. Rev. Cancer 6 2006 813
22. M. Basson Nat. Med. 16 2010 372
23. R. Graeser, N. Esser, H. Unger, I. Fichtner, A. Zhu, C. Unger, and F. Kratz Invest. New Drugs 28 2010 14
24. R.A. Weinberg A Biologia do Câncer 2008 Artmed Porto Alegre Chapter 16
25. B.B. Aggarwal, R.V. Vijayalekshmi, and B. Sung Clin. Cancer Res. 15 2009 425
26. A. Mantovani Medicina 67 2007 32
27. I. Posadas, M. Bucci, F. Roviezzo, A. Rossi, L. Parente, L. Sautebin, and G. Cirino Br. J. Pharmacol. 142 2004 331
28. F.P.B. Nunes, S.C. Sampaio, M.L. Santoro, and M.C.C. Sousa-e-Silva Toxicon 49 2007 1090
29. M.A. Pedernera, T. Guardia, C.E.G. Calderón, A.E. Rotelli, N.E. de la Rocha, J.R. Saad, M.A.L. Verrilli, S.G. Aseff, and L.E. Pelzer Inflammopharmacology 2010 10.1007/s10787-009-0028-6
30. T.S. Fröde, G.E.P. Souza, and J.B. Calixto Cytokine 13 2001 162
31. Wang, D.; DuBoi, R. N. Nat. Rev. Cancer AOP 2010, doi:10.1038/nrc2809.
32. D.J.A. de Groot, E.G.E. de Vries, H.J.M. Groen, and S. de Jong Crit. Rev. Oncol. Hematol. 61 2007 52
33. Lapa, A. J.; Souccar, C.; Lima-Landman, M. T. R.; Castro, M. S. A.; Lima, T. C. M. Métodos de avaliaão da atividade farmacológica de plantas medicinais. 5. Ed-Setor de Produtos Naturais, Departamento de Farmacologia, UNIFESP/EPM, 2008.
34. J.T. Litchfield Jr., and F. Wilcoxon J. Pharmacol. Exp. Ther. 96 1949
35. S.R. Kleeb, M.S. Rizzo, M.L.Z. Dagli, and R. Frussa-Filho Int. J. Immunopharmacol. 21 1999 575